ReviewCells2018

Inhibitory-κB Kinase (IKK) α and Nuclear Factor-κB (NFκB)-Inducing Kinase (NIK) as Anti-Cancer Drug Targets.

Andrew Paul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.